TNFRSF12A and cancer: The TWEAK-overexpressing cells had elevated levels of Fn14 expression, consistent with earlier reports demonstrating that TWEAK treatment of cancer cell lines increases Fn14 mRNA [48, 62] and protein [55, 62] levels and that TWEAK administration increases Fn14 gene expression in murine peritoneal tissue in vivo [33].